Unveiling 6 Analyst Insights On Treace Medical Concepts
Unveiling 6 Analyst Insights On Treace Medical Concepts
公佈分析師對Treace醫療概念的6點見解
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
6位分析師提供的分析師對Treace Medical Concepts（納斯達克股票代碼：TMCI）在上個季度的評級從看漲到看跌不等。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.17, a high estimate of $16.00, and a low estimate of $5.50. A negative shift in sentiment is evident as analysts have decreased the average price target by 48.39%.
分析師分析的12個月目標股價提供了見解，平均目標價爲8.17美元，最高估計爲16.00美元，低估值爲5.50美元。隨着分析師將平均目標股價下調了48.39％，情緒的負面轉變顯而易見。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
A comprehensive examination of how financial experts perceive Treace Medical...
對金融專家如何看待T...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。